Comparison of the influence of omalizumab and mepolizumab on airway remodeling in severe asthma patients with evaluation of detection techniques: endobronchial ultrasound (EBUS) and high-resolution computed tomography (HRCT)

Source: International Congress 2022 – Chronic airway diseases: from phenotypes to severity

Session: Chronic airway diseases: from phenotypes to severity
Session type: Oral Presentation
Number: 1410

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Przybyszowski (Kraków, Poland), W. Zastrzezynska (Kraków, Poland), A. Gawlewicz-Mroczka (Kraków, Poland), I. Gross-Sondej (Kraków, Poland), J. Zarychta (Zakopane, Poland), S. Bazan-Socha (Kraków, Poland), G. Bochenek (Kraków, Poland), J. Soja (Kraków, Poland), K. Sladek (Kraków, Poland). Comparison of the influence of omalizumab and mepolizumab on airway remodeling in severe asthma patients with evaluation of detection techniques: endobronchial ultrasound (EBUS) and high-resolution computed tomography (HRCT). 1410

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

• Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
• Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
• Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study